Novartis (NYSE: NVS) is paying $1.1 billion upfront to buy Myricx Bio, a London-based biotech with its U.S. presence based in ...

Hospitals and health systems are rapidly adopting AI-powered tools, connected medical devices, advanced analytics and emerging biotechnology solutions. Most organizations evaluate these technologies ...

David Craig’s operating manual for building biotech companies in today’s market is now available in hardcover and as an ...

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Five of the biggest names in American pharma just got a deadline from Washington. The House Select Committee on China sent ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares ...

Seven life sciences companies cut at least 346 jobs in Massachusetts between April and June, with some of the layoffs tied to ...

The chair of the U.S. House Select Committee on China opened national security investigations into whether five drugmakers ...

Dr. Jessica Maloh to lead Continuing Medical Education session 'The Biology of Breakouts”; Codex Labs to feature its plant-biotech acne portfolio and Decode.Me integrative dermatology platform ...

TheFly reported on June 15 that Oppenheimer initiated coverage of AAPG with an Outperform rating and a $45 price target.

Biotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb domestic ...